Logo 13 Oct 2025

New clinical trial reg provides path to commercialization for Chinese biomedical tech

Subscribe to keep reading.

Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.

Try it free

Already a subscriber? Log in.

China's new regulation on trialing biomedical technology – approved by the State Council last month and released in full on Friday – provides a clear path from clinical trials to widespread application for the first time.
The reg covers frontier biomedical technologies like:

Cell and gene therapies...



More recent developments

Logo October 14, 2025
State Council releases AI+Government Services

On October 10, the State Council released new guidelines governing the use of AI tools by government agencies. Background: China's AI+ policy, released in August, called on officials to use artificial intelligence to improve government efficiency. This document provides more… Read More »

Logo October 14, 2025
Trump threatens controls on “all critical software”

Over the weekend, President Trump lashed out over China’s sweeping new rare earth export controls. In a post on Truth Social, Trump threatened to impose a 100% tariff on all Chinese goods by November 1. He also vowed to impose… Read More »

Logo October 11, 2025
MofCom sanctions TechInsights

What happened: On October 9, the Ministry of Commerce (MofCom) placed semiconductor data provider TechInsights and its subsidiaries on the Unreliable Entity List (UEL), along with 13 other companies. The move was announced as part of a suite of export… Read More »